The US Drug Eluting Sinus Stent (DESS) Market:Size, Trends & Forecasts (2021-2025 Edition)
The key players of the drug eluting sinus stent (DESS) market areIntersect ENT, Inc., Medtronic plc, Stryker Corporation (Entellus Medical,Inc.), and Johnson & Johnson (Acclarent, Inc.) are also profiled in this report.
By: Daedal Research
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the US drug eluting sinus stent (DESS) market has also been forecasted for the period 2021-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
Intersect ENT, Inc.
Stryker Corporation (Entellus Medical, Inc.)
Johnson & Johnson (Acclarent, Inc.)
Sinusitis can be divided into Acute Sinusitis, Recurrent Acute Rhinosinusitis (RARS) and chronic Rhinosinusitis (CRS), on the basis of the duration of the episode of sinusitis and its severity. The treatment options for the sinusitis can be over-the-counter treatment, medical management and surgery. The OTC treatment includes decongestants, antihistamines, pain relievers and nasal irrigation. Medical management includes antibiotics and oral and nasal steroids. The sinus surgeries are mainly of two types: Functional Endoscopic Sinus Surgery (FESS) and Balloon Sinus Dilation (BSD).
The US drug eluting sinus stent (DESS) market has increased significantly during the years 2018-2020, and projections are made that the market would rise in the next four years i.e. 2021-2025 tremendously. The drug eluting sinus stent (DESS) market is expected to increase due to surging healthcare expenditure, increasing prevalence of sinus related disorders, growing treatment in physician's office, limitations of FESS, favorable government initiatives for promoting the use of sinus stents, etc. Yet the market faces some challenges such as economic slowdown, high cost involved, use of oral steroids and packing material, etc.
For further details, kindly visit :
(Business Development Manager)
Address: 36 SFS Flats
Mail ID - info@daedal-